OTC

"Likes" put Zarbee's in FDA crosshairs

"Likes" put Zarbee's in FDA crosshairs

By

The FDA says the OTC remedy maker's online behavior—including Liking customer Facebook posts—has put the company's drugs in unapproved drug territory.

Bayer buys Merck OTC portfolio

Bayer buys Merck OTC portfolio

By

The $14.2-billion deal is expected to close in the second half of this year.

GSK, Novartis, Lilly play musical chairs

GSK, Novartis, Lilly play musical chairs

By

The three drugmakers rearranged part of the pharma universe Tuesday with a string of pipeline-altering deals.

Advil hearts menstrual cramps

Advil hearts menstrual cramps

By

Pfizer's consumer website for Advil in South Korea offers a strange appeal to women who experience menstrual pain.

Study: OTC stomach meds trigger upset

Mintel finds consumers are wary about how OTC stomach medicines, like Rolaids, may affect their health.

Medicate responsibly, urges maker of Tylenol

Medicate responsibly, urges maker of Tylenol

By

J&J's campaign picks up where the FDA left off when it alerted physicians to concerns about prescribing acetaminophen-containing drugs but deferred action relative to OTC products.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.